Summary of project PR000716
This data is available at the NIH Common Fund's National Metabolomics Data Repository (NMDR) website, the Metabolomics Workbench, https://www.metabolomicsworkbench.org, where it has been assigned Project ID PR000716. The data can be accessed directly via it's Project DOI: 10.21228/M8496H This work is supported by NIH grant, U2C- DK119886.
See: https://www.metabolomicsworkbench.org/about/howtocite.php
Project ID: | PR000716 |
Project DOI: | doi: 10.21228/M8496H |
Project Title: | Evaluation of TB Treatment Response Biomarkers |
Project Type: | Directed MS analysis |
Project Summary: | Directed MS analysis of promising treatment response biomarkers in TB patient urine. |
Institute: | Colorado State University |
Department: | Department of Microbiology, Immunology, and Pathology |
Laboratory: | Belisle |
Last Name: | Fitzgerald |
First Name: | Bryna |
Address: | 3185 Rampart Rd, Fort Collins, CO, 80521, USA |
Email: | blfitz@colostate.edu |
Phone: | 9704918905 |
Funding Source: | NIH U01 AI-115619 |
Summary of all studies in project PR000716
Study ID | Study Title | Species | Institute | Analysis(* : Contains Untargted data) | Release Date | Version | Samples | Download(* : Contains raw data) |
---|---|---|---|---|---|---|---|---|
ST001069 | Evaluation of Seryl-leucine core 1 O-glycosylated peptide (SLC1G) in TB patient urine | Homo sapiens | Colorado State University | MS | 2018-12-11 | 1 | 229 | Uploaded data (1.4G)* |
ST001104 | Seryl-leucine core 1 O-glycosylated peptide (SLC1G) identification | Homo sapiens | Colorado State University | MS* | 2019-01-22 | 1 | 9 | Uploaded data (1.5G)* |